Cargando…
Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
As an appealing alternative to treat and prevent diseases ranging from cancer to COVID-19, mRNA has demonstrated significant clinical effects. Nanotechnology facilitates the successful implementation of the systemic delivery of mRNA for safe human consumption. In this manuscript, we provide an overv...
Autores principales: | Puccetti, Matteo, Schoubben, Aurelie, Giovagnoli, Stefano, Ricci, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917085/ https://www.ncbi.nlm.nih.gov/pubmed/36768539 http://dx.doi.org/10.3390/ijms24032218 |
Ejemplares similares
-
Pharmaceutically Active Microbial AhR Agonists as Innovative Biodrugs in Inflammation
por: Puccetti, Matteo, et al.
Publicado: (2022) -
Turning Microbial AhR Agonists into Therapeutic Agents via Drug Delivery Systems
por: Puccetti, Matteo, et al.
Publicado: (2023) -
Pharmacological Functions, Synthesis, and Delivery Progress for Collagen as Biodrug and Biomaterial
por: Zhou, Nan, et al.
Publicado: (2023) -
Ketorolac Loaded Poly(lactic-co-glycolic acid) Coating of AZ31 in the Treatment of Bone Fracture Pain
por: Puccetti, Matteo, et al.
Publicado: (2023) -
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
por: Puccetti, Matteo, et al.
Publicado: (2020)